Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
4,296,332
-
Shares change
-
-82,395
-
Total reported value, excl. options
-
$58,903,257
-
Value change
-
-$336,681
-
Put/Call ratio
-
646%
-
Number of buys
-
41
-
Number of sells
-
27
-
Price
-
$13.71
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2020
As of 30 Jun 2020 XBiotech Inc. - Common Shares, no par value (XBIT) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,296,332 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, JANE STREET GROUP, LLC, Russell Investments Group, Ltd., ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, AQR CAPITAL MANAGEMENT LLC, and Nuveen Asset Management, LLC.
This table shows 85 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.